The Recall Desk
Agency classClass IIOur severity:ModerateFDA (Drugs)·D-1259-2015·Announced 2015-07-29

Wockhardt Recalls Lisinopril Tablets Due to CGMP Deviations

Wockhardt USA Inc. is recalling Lisinopril Tablets USP, 20 mg, due to inadequate investigation of customer complaints. The recall covers nationwide distribution.

The agency’s classification

FDA (Drugs): Class II

Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.

This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work

What this means for you

Our assessment, not the agency’s: severity 2/5 (Moderate).

Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.

Our severity reasoning: The recall is classified as FDA Class II due to CGMP deviations (inadequate complaint investigation) without reported illnesses or injuries, fitting the criteria for moderate severity.

Plain-English summary

Wockhardt USA Inc. is recalling Lisinopril Tablets USP, 20 mg, in 100, 500, and 1000 count bottles. The product is prescription-only and was distributed nationwide, including Puerto Rico.

The recall was initiated because the firm did not adequately investigate customer complaints, which constitutes a Current Good Manufacturing Practice (CGMP) deviation. The agency classified this recall as Class II.

Consumers should stop using the affected products and contact their healthcare provider or pharmacist for a replacement. The specific lot numbers and expiration dates are listed in the official recall notice.

The recalled product

Product
Lisinopril Tablets USP, 20 mg Tablets, Packaged in A) 100 Count Bottles (NDC: 64679-941-01), B) 500 Count Bottles (NDC: 64679-941-05), and C) 1000 Count Bottles (NDC: 64679-941-06), Rx Only. Manufactured by: Wockhardt Limited, Mumbai, India. Distributed by: Wockhardt USA LLC 20…
Manufacturer
Wockhardt Usa Inc.
Category
Drug — Prescription Medication
Hazard

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (20)

  • A) Lot #: DM11334
  • Expiry: 4/30/2015
  • Lot #: DM11551
  • Expiry: 6/30/2015
  • Lot #: DM11995
  • Expiry: 7/31/2015
  • Lot #: DM12007
  • Lot #: DM12480
  • Expiry: 8/31/2015
  • Lot #: DN10255
  • Expiry: 12/31/2015
  • Lot #: DN10410
  • Expiry: 1/31/2016
  • Lot #: DN10897
  • Expiry: 2/29/2016. B) Lot #: DM11556
  • Lot #: DM11567
  • Lot #: DM12008
  • Lot #: DM12482
  • Expiry: 8/31/2015. C) Lot #: DM11119
  • Lot #: DM11131

Distribution

Distributed nationwide across the United States.

The notice also names 1 state specifically:

Part of a larger recall action

This product is one of 35 recalled by Wockhardt Usa Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.

See all 35 products in this recall →

Related recalls

Same manufacturer · Wockhardt Usa Inc.

See all →

Same hazard · cgmp deviation

See all →

Similar recalls